Less than a week after breaking out of a base, Facebook (FB) is threatening to make a round trip. Shares fell 1.7% to 86.52 in above-average volume in the stock market today. At one point, Facebook was trading only 5 cents above an 86.17 buy point from a flat base. But the stock was able to find support at that level and make back some of those losses. Facebook initially broke out of the base last Tuesday, gaining 4% in quick turnover. The stock
Specialty drugmaker AMAG Pharmaceuticals (AMAG) agreed to acquire stem-cell bank Cord Blood Registry for $700 million Monday, sending AMAG’s stock on a volatile ride. CBR owns about 600,000 units of umbilical-cord blood and tissue stem cells, which its partners use in medical research. Last year, the company drew $126 million in revenue, about the same as AMAG itself, which currently gets its income from three drugs used to treat anemia and oral
Social networking king Facebook (FB) is testing a photo feature that seems a lot like Snapchat, the hot messaging app launched in 2011 that lets users add captions and drawings to their photos and videos — aka “snaps.” Facebook is mimicking Snapchat as it tests a new photo uploader that lets users add text in any color, instantly preview filters to be swiped across photos, or paste on Facebook’s re-sizeable emoji virtual stickers, according to a